文摘
Survival for patients with nonurothelial subtypes is worse than urothelial at 5 years. Nonurothelial bladder cancer incurs a higher rate of T upstaging at cystectomy. Neoadjuvant therapy is used infrequently in nonurothelial disease. Aggressive treatment, including neoadjuvant chemotherapy, should be considered.